![Patrick Crutcher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Crutcher
No open positions remaining
Net worth: 11 M $ as of 30/06/2026
Profile
Patrick J.
Crutcher is Chief Executive Officer at Mach5 Therapeutics, Inc. and Independent Director at Amanat Acquisition Corp.
Former roles include President & Chief Executive Officer at AlmataBio, Inc., Chairman & President at Ichorion Therapeutics, Inc. from 2017 to 2018, and Chief Strategy Officer at Avalo Therapeutics, Inc. in 2019.
Education includes graduate studies at the University of California, Los Angeles and undergraduate studies at the University of Illinois.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 06/08/2025 | 549,467 ( 1.04% ) | 10 M $ | 30/06/2026 | |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins 0.87% | 30/06/2025 | 300,438 ( 0.87% ) | 525 767 $ | 30/06/2026 |
1.15% | 20/05/2026 | 25,000 ( 1.15% ) | 254 000 $ | 30/06/2026 |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy 1.85% | 16/07/2026 | 518,331 ( 1.85% ) | 218 217 $ | 30/06/2026 |
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy 9.98% | 20/07/2026 | 463,452 ( 9.98% ) | 195 113 $ | 30/06/2026 |
Patrick Crutcher active positions
| Companies | Position | Start |
|---|
Former positions of Patrick Crutcher
| Companies | Position | End |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2019 |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceutical products | Chief Executive Officer | 01/09/2018 |
Training of Patrick Crutcher
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Patrick Crutcher
